ANIK vs CUBE · rev $119.9M vs P/E 25, rev $1.07B
Anika Therapeutics Inc (ANIK) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported ANIK revenue for 2024-12-31 was $119.9M. Net income was -$56.4M. Revenue was down 0.7% from 2023-12-31 to 2024-12-31. ANIK currently screens at market cap $161.3M.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
ANIK currently screens at market cap $161.3M. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the ANIK and CUBE stock pages for the full models.
Not investment advice.